Back

Inflammation-associated HDL dysfunction in acute coronary syndrome: role of serum amyloid A

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: New insights into biomarkers, inflammation, and outcomes in coronary artery disease Inflammation and Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Konstantin Gospodinov

Medical University Pleven, Pleven (Bulgaria)

5 More presentations in this session

Presentation thumbnail
Impact of the systemic immune-inflammation index (sii) on prognosis in patients with chronic total occlusion (CTO): a systematic review and meta-analysis
Doctor S. Saenz Ancira (Bronx, US)
Abstract Slides
Presentation thumbnail
Serum plasminogen improves early detection of acute coronary syndrome in high sensitivity troponin t-negative chest pain patients
Doctor O. Tupayachi Villagomez (Milano, IT)
Abstract Slides
Presentation thumbnail
Prehospital medical treatment of hypertensive emergencies in patients with suspected acute coronary syndrome or heart failure – a pilot real-world observational study
Doctor D. Szabo (Budapest, HU)
Abstract Slides
Presentation thumbnail
Functional residual ischemia and ventricular function drive symptomatic outcomes after PCI
Doctor P. Alexiou (Lucerne, CH)
Abstract Slides
Presentation thumbnail
Twelve months of exercise training did not alter coronary flow reserve or microvascular resistance reserve in patients with old myocardial infarction
Doctor C. Saeland (Stavanger, NO)
Abstract Slides

Access the full session

Session thumbnail
New insights into biomarkers, inflammation, and outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of phase ii exercise-based cardiac rehabilitation on HDL-c levels and the predictive role of systemic inflammatory index in patients with coronary artery disease
3 April 2025
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021
thumbnail
Congress Presentation
Circulating markers of autophagy dysfunction are associated with coronary artery disease in patients undergoing coronary angiography
1 September 2025
thumbnail
Congress Presentation
Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources